Literature DB >> 35920299

Mcm2 hypomorph leads to acute leukemia or hematopoietic stem cell failure, dependent on genetic context.

Toshihiro Matsukawa1, Mianmian Yin1, Timour Baslan2, Yang Jo Chung1, Dengchao Cao1, Ryan Bertoli1, Yuelin J Zhu1, Robert L Walker1, Amy Freeland3, Erik Knudsen3, Scott W Lowe2,4, Paul S Meltzer1, Peter D Aplan1.   

Abstract

Minichromosome maintenance proteins (Mcm2-7) form a hexameric complex that unwinds DNA ahead of a replicative fork. The deficiency of Mcm proteins leads to replicative stress and consequent genomic instability. Mice with a germline insertion of a Cre cassette into the 3'UTR of the Mcm2 gene (designated Mcm2Cre ) have decreased Mcm2 expression and invariably develop precursor T-cell lymphoblastic leukemia/lymphoma (pre-T LBL), due to 100-1000 kb deletions involving important tumor suppressor genes. To determine whether mice that were protected from pre-T LBL would develop non-T-cell malignancies, we used two approaches. Mice engrafted with Mcm2Cre/Cre Lin- Sca-1+ Kit+ hematopoietic stem/progenitor cells did not develop hematologic malignancy; however, these mice died of hematopoietic stem cell failure by 6 months of age. Placing the Mcm2Cre allele onto an athymic nu/nu background completely prevented pre-T LBL and extended survival of these mice three-fold (median 296.5 vs. 80.5 days). Ultimately, most Mcm2Cre/Cre ;nu/nu mice developed B-cell precursor acute lymphoblastic leukemia (BCP-ALL). We identified recurrent deletions of 100-1000 kb that involved genes known or suspected to be involved in BCP-ALL, including Pax5, Nf1, Ikzf3, and Bcor. Moreover, whole-exome sequencing identified recurrent mutations of genes known to be involved in BCP-ALL progression, such as Jak1/Jak3, Ptpn11, and Kras. These findings demonstrate that an Mcm2Cre/Cre hypomorph can induce hematopoietic dysfunction via hematopoietic stem cell failure as well as a "deletor" phenotype affecting known or suspected tumor suppressor genes.
© 2022 Federation of American Societies for Experimental Biology. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.

Entities:  

Keywords:  B-cell precursor acute lymphoblastic leukemia; DNA stress; Mcm2; bone marrow failure; tumor suppressor gene

Mesh:

Substances:

Year:  2022        PMID: 35920299      PMCID: PMC9377154          DOI: 10.1096/fj.202200061RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.834


  51 in total

1.  Uninterrupted MCM2-7 function required for DNA replication fork progression.

Authors:  K Labib; J A Tercero; J F Diffley
Journal:  Science       Date:  2000-06-02       Impact factor: 47.728

2.  Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype.

Authors:  Vera Grossmann; Enrico Tiacci; Antony B Holmes; Alexander Kohlmann; Maria Paola Martelli; Wolfgang Kern; Ariele Spanhol-Rosseto; Hans-Ulrich Klein; Martin Dugas; Sonja Schindela; Vladimir Trifonov; Susanne Schnittger; Claudia Haferlach; Renato Bassan; Victoria A Wells; Orietta Spinelli; Joseph Chan; Roberta Rossi; Stefano Baldoni; Luca De Carolis; Katharina Goetze; Hubert Serve; Rudolf Peceny; Karl-Anton Kreuzer; Daniel Oruzio; Giorgina Specchia; Francesco Di Raimondo; Francesco Fabbiano; Marco Sborgia; Arcangelo Liso; Laurent Farinelli; Alessandro Rambaldi; Laura Pasqualucci; Raul Rabadan; Torsten Haferlach; Brunangelo Falini
Journal:  Blood       Date:  2011-10-19       Impact factor: 22.113

3.  Excess MCM proteins protect human cells from replicative stress by licensing backup origins of replication.

Authors:  Arkaitz Ibarra; Etienne Schwob; Juan Méndez
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-25       Impact factor: 11.205

Review 4.  DNA replication stress as a hallmark of cancer.

Authors:  Morgane Macheret; Thanos D Halazonetis
Journal:  Annu Rev Pathol       Date:  2015       Impact factor: 23.472

Review 5.  The SCID mouse mutant: definition, characterization, and potential uses.

Authors:  M J Bosma; A M Carroll
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

6.  NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia.

Authors:  S Z Raza-Egilmez; S N Jani-Sait; M Grossi; M J Higgins; T B Shows; P D Aplan
Journal:  Cancer Res       Date:  1998-10-01       Impact factor: 12.701

7.  NUP98-PHF23 is a chromatin-modifying oncoprotein that causes a wide array of leukemias sensitive to inhibition of PHD histone reader function.

Authors:  Sheryl M Gough; Fan Lee; Fan Yang; Robert L Walker; Yeulin J Zhu; Marbin Pineda; Masahiro Onozawa; Yang Jo Chung; Sven Bilke; Elise K Wagner; John M Denu; Yi Ning; Bowen Xu; Gang Greg Wang; Paul S Meltzer; Peter D Aplan
Journal:  Cancer Discov       Date:  2014-02-17       Impact factor: 39.397

8.  A unique mutator phenotype reveals complementary oncogenic lesions leading to acute leukemia.

Authors:  Mianmian Yin; Timour Baslan; Robert L Walker; Yuelin J Zhu; Amy Freeland; Toshihiro Matsukawa; Sriram Sridharan; André Nussenzweig; Steven C Pruitt; Scott W Lowe; Paul S Meltzer; Peter D Aplan
Journal:  JCI Insight       Date:  2019-12-05

9.  Mcm2 deficiency results in short deletions allowing high resolution identification of genes contributing to lymphoblastic lymphoma.

Authors:  M E Rusiniak; D Kunnev; A Freeland; G K Cady; S C Pruitt
Journal:  Oncogene       Date:  2011-12-12       Impact factor: 9.867

10.  Replication stress caused by low MCM expression limits fetal erythropoiesis and hematopoietic stem cell functionality.

Authors:  Silvia Alvarez; Marcos Díaz; Johanna Flach; Sara Rodriguez-Acebes; Andrés J López-Contreras; Dolores Martínez; Marta Cañamero; Oscar Fernández-Capetillo; Joan Isern; Emmanuelle Passegué; Juan Méndez
Journal:  Nat Commun       Date:  2015-10-12       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.